Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • friducha
    Junior Member
    • Jan 2015
    • 9

    #1

    Why sum technical replicates instead of averaging (and rounding) for DESeq?

    It is widely recommended to sum technical replicate samples for differential gene expression analysis.
    I was wondering why this is the case, and not averaging the technical replicates into a single value for the individual?
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    I suppose that summing would give greater statistical power. If you have 10 replicates, each with 1 read mapped to some gene, then the sum would be 10 and the average 1. 1 event is a lot more likely to be noise than 10 events.

    Aside from that, averaging and rounding would lose precision for no gain.

    Comment

    • bjackson
      Junior Member
      • May 2015
      • 6

      #3
      I just ended up asking a very similar question looking for guidance. When you say 'widely recommended' can you provided a paper or technical reference that says this? That would help me greatly.

      Comment

      • Michael Love
        Senior Member
        • Jul 2013
        • 333

        #4
        There is a theoretical justification. The sum of Poisson RVs (random variables) is Poisson. Raw counts of uniquely assigned reads to genes are very close to Poisson distribution across technical replicates. And the statistical model includes Poisson RVs or RVs with higher dispersion (due to biological variation). So the sum is a good idea for summarizing technical replicates.

        Note that the average of Poissons is not Poisson, for example, it has less variance than the mean. Suppose we take the mean of 5 Poisson RVs with lambda=10 and call this new thing X. The expected value will be 10,

        > mean(replicate(1000, mean(rpois(5, lambda=10))))
        [1] 9.9804

        but the variance of X is now less than the mean:

        > var(replicate(1000, mean(rpois(5, lambda=10))))
        [1] 1.951687

        This kind of a RV, a count which is under-dispersed, is not possible to model with the count-based methods.

        Comment

        • stormin
          Member
          • Aug 2014
          • 23

          #5
          Sorry to dig up the old post, I think my question is relevant to this discussion.

          From practical point of view, technical replicates from the same RNA sample can be merged together into a single fastq file for mapping and subsequent counting. Is this the correct approach?

          Alternatively, should mapping be done separately and counts added subsequently? Tophat is my current mapper, but please commend on whether this works with other mappers. Thanks

          Comment

          • dpryan
            Devon Ryan
            • Jul 2011
            • 3478

            #6
            It doesn't really matter if you map and merge or merge and then map, you'll get essentially the same results regardless. This is true regardless of the aligner.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 10:52 AM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            17 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...